FDA Approves TriClip TEER System for Tricuspid Regurgitation
Less than 2 months after being the subject of an FDA AdComm meeting, Abbott's TriClip TEER System has received approval for tricuspid regurgitation.
Source: hcplive.com
System Devices Panel News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from System Devices Panel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In System Devices Panel Today - Breaking & Trending Today
FDA Approves TriClip TEER Device for Tricuspid Repair
The approval was based on positive data from the TRILUMINATE pivotal trial, which included a highly symptomatic population.
Source: tctmd.com
FDA Clears TriClip for Tricuspid Regurgitation
The approval follows an FDA advisory committee vote in favor of Abbott's TriClip Transcatheter Edge-to-Edge Repair system for repair of severe tricuspid regurgitation.
Source: medscape.com
FDA Panel Votes in Favor of Abbott TriClip for Tricuspid Regurgitation
HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.
Source: hcplive.com
Cardiology's Quantum Leap: FDA's Advisory Panel Gives Thumbs Up To Abbott's Minimally Invasive Heart Valve Repair Device - Abbott Laboratories (NYSE:ABT)
FDA panel confirms support (13-1) for Abbott Laboratories' TriClip TEER system in treating tricuspid regurgitation. Approval decision expected from FDA in 2024.
Source: benzinga.com